Single-Dose HPV Vaccination for the Prevention of Cervical Cancer in Young Adult Women in Costa Rica, The PRISMA ESCUDDO Trial
Conditions:   Cervical Carcinoma;   Human Papillomavirus Infection Interventions:   Biological: Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed;   Other: Questionnaire Administration;   Biological: Recombinant Human Papillomavirus Bivalent Vaccine;   Biological: Recombinant Human Papillomavirus Nonavalent Vaccine Sponsor:   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2022 Category: Research Source Type: clinical trials